BNP Paribas’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
BNP Paribas's AMGN Position: Q1 2026 in Review
BNP Paribas reduced its Amgen (AMGN) stake by 4.1% in Q1 2026, selling an estimated $824K and leaving 53,912 shares worth $19M. The position accounts for 0.6% of the portfolio, ranked #35.
BNP Paribas first reported a position in AMGN in Q1 2024 and has held it in 9 quarters since. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- BNP Paribas held 53,912 shares of Amgen worth $19M as of Q1 2026.
- BNP Paribas sold 2,312 Amgen shares in Q1 2026, an estimated $824K.
- Amgen made up 0.6% of BNP Paribas's portfolio in Q1 2026, its #35 holding.
- BNP Paribas first reported a position in Amgen in Q1 2024 and has held it in 9 quarters since.
- 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on BNP Paribas's 13F filing for Q1 2026, filed 12 May 2026.